1. Home
  2. CORT vs NAVN Comparison

CORT vs NAVN Comparison

Compare CORT & NAVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$59.99

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

NAVN

Navan Inc.

N/A

Current Price

$19.79

Market Cap

4.0B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
NAVN
Founded
1998
2015
Country
United States
United States
Employees
N/A
3700
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
CORT
NAVN
Price
$59.99
$19.79
Analyst Decision
Buy
Strong Buy
Analyst Count
5
13
Target Price
$96.50
$20.92
AVG Volume (30 Days)
1.1M
3.0M
Earning Date
04-30-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$761,407,000.00
N/A
Revenue This Year
$26.08
$26.56
Revenue Next Year
$26.98
$22.98
P/E Ratio
N/A
N/A
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$8.11
52 Week High
$91.00
$20.27

Technical Indicators

Market Signals
Indicator
CORT
NAVN
Relative Strength Index (RSI) 74.52 73.56
Support Level $32.95 $13.61
Resistance Level $90.00 N/A
Average True Range (ATR) 2.29 1.00
MACD 0.41 -0.11
Stochastic Oscillator 92.09 97.90

Price Performance

Historical Comparison
CORT
NAVN

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About NAVN Navan Inc.

Navan Inc is engaged in providing an end-to-end, AI-powered software platform for managing business travel and expense (T&E). The company's platform enables users to manage corporate travel bookings, payments, and expense processes, while providing tools for customers to control and optimize spending and for suppliers to access demand. Geographically, the company operates in the United States, the United Kingdom, and other countries, with the majority of its revenue generated from the United States.

Share on Social Networks: